Metraipolis › archive › dc_1d9ca1d0fffc

Polymerase-inhibitor drug synergy and mutational signatures in different epithelial cell models of RSVA and hPIV3 infection — Europe PMC PMID:42215780

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42215780
DOI
10.1038/s44259-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-01T05:05:32.000Z
SHA-256 of the archived text
e78c3f56ce1451fce51e744cf73110011b0f29d5f8fda6a2866b366733d3e23f
Stable URL of this page
https://metraipolis.com/documento/dc_1d9ca1d0fffc

How to cite

Polymerase-inhibitor drug synergy and mutational signatures in different epithelial cell models of RSVA and hPIV3 infection — Europe PMC PMID:42215780 — Europe PMC (en), https://europepmc.org/article/MED/42215780 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1d9ca1d0fffc (Metraipolis archive dc_1d9ca1d0fffc, sha256 e78c3f56ce1451fce51e744cf73110011b0f29d5f8fda6a2866b366733d3e23f)
BibTeX
@misc{dc1d9ca1d0fffc,
  title = {Polymerase-inhibitor drug synergy and mutational signatures in different epithelial cell models of RSVA and hPIV3 infection — Europe PMC PMID:42215780},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42215780},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1d9ca1d0fffc; sha256 e78c3f56ce1451fce51e744cf73110011b0f29d5f8fda6a2866b366733d3e23f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42215780. Agents can read the archived copy with the MCP tool read_document.